MRT Inc. (JP:6034)
:6034
Top Page
MRT Inc.
(6034)
Select Model
Select Model
Rating:54Neutral
Price Target:
¥663.00
▲(5.24% Upside)
Action:ReiteratedDate:03/24/26
The score is driven primarily by mixed financial performance: a weak and volatile income statement is partially offset by a conservative balance sheet and generally positive recent cash generation. Technical indicators are broadly neutral, while valuation is a meaningful headwind due to the high P/E and no provided dividend yield.
Positive Factors
Conservative balance sheet
Modest leverage and a meaningful equity base provide lasting financial flexibility. Reduced debt versus 2024 means the firm can absorb shocks, fund selective investment or R&D, and avoid forced financing in downturns, supporting stability over the next 2–6 months.
Negative Factors
Volatile profitability and thin operating margins
Earnings volatility and persistently thin operating and net margins reduce resilience to revenue shocks and increase execution risk. Thin margins constrain retained earnings and ROE, limiting the firm's ability to build durable internal funds for growth or cushioning future downturns.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Modest leverage and a meaningful equity base provide lasting financial flexibility. Reduced debt versus 2024 means the firm can absorb shocks, fund selective investment or R&D, and avoid forced financing in downturns, supporting stability over the next 2–6 months.
Read all positive factors
MRT Inc. (6034) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥3.52B
Dividend YieldN/A
Average Volume (3M)6.11K
Price to Earnings (P/E)63.0
Beta (1Y)0.14
Revenue Growth1.51%
EPS Growth-13.66%
CountryJP
Employees304
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)-3.60
Shares Outstanding5,718,600
10 Day Avg. Volume13,250
30 Day Avg. Volume6,110
Financial Highlights & Ratios
PEG Ratio-0.54
Price to Book (P/B)0.76
Price to Sales (P/S)0.84
P/FCF Ratio8.57
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
MRT Inc. Business Overview & Revenue Model
Company Description
MRT Inc. operates a medical information platform. The company provides temporary and part-time doctor services; doctor's career change support service; Door., an app to connect network of doctors; Door.into, which provides online health counseling...
MRT Inc. Financial Statement Overview
Summary
Income Statement
48
Neutral
Balance Sheet
72
Positive
Cash Flow
66
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 4.19B | 4.17B | 5.41B | 8.74B | 4.47B |
| Gross Profit | 2.60B | 2.48B | 3.27B | 5.41B | 3.37B |
| EBITDA | 331.35M | 165.42M | 1.20B | 3.16B | 1.61B |
| Net Income | 55.77M | -309.16M | 518.36M | 2.16B | 774.49M |
Balance Sheet | |||||
| Total Assets | 6.48B | 6.75B | 6.47B | 8.16B | 4.98B |
| Cash, Cash Equivalents and Short-Term Investments | 1.67B | 2.61B | 3.78B | 4.89B | 1.01B |
| Total Debt | 552.97M | 1.05B | 641.79M | 875.86M | 1.04B |
| Total Liabilities | 1.83B | 2.12B | 1.76B | 3.67B | 2.69B |
| Stockholders Equity | 4.65B | 4.52B | 4.58B | 4.39B | 2.22B |
Cash Flow | |||||
| Free Cash Flow | 409.83M | 461.79M | -208.76M | 4.50B | -308.61M |
| Operating Cash Flow | 417.84M | 503.04M | -193.58M | 4.51B | -298.89M |
| Investing Cash Flow | -623.37M | -1.84B | -243.61M | -431.11M | -206.51M |
| Financing Cash Flow | -730.16M | 161.77M | -669.19M | -203.98M | -67.49M |
MRT Inc. Technical Analysis
Negative
630.00
Price Trends
641.86
Negative
643.41
Negative
669.55
Negative
Market Momentum
-3.59
Positive
46.86
Neutral
38.36
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6034, the sentiment is Negative. The current price of 630 is below the 20-day moving average (MA) of 638.20, below the 50-day MA of 641.86, and below the 200-day MA of 669.55, indicating a bearish trend. The MACD of -3.59 indicates Positive momentum. The RSI at 46.86 is Neutral, neither overbought nor oversold. The STOCH value of 38.36 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:6034.
MRT Inc. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | ¥65.63B | 228.03 | ― | 0.39% | 6.17% | -8918.66% | |
54 Neutral | ¥3.52B | 62.95 | ― | ― | 1.51% | -13.66% | |
52 Neutral | ¥7.80B | 33.39 | ― | ― | 41.16% | 2750.91% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | ¥6.44B | 10.51 | ― | ― | -4.07% | -88.89% | |
44 Neutral | ¥2.71B | -4.28 | ― | ― | 16.19% | -4.42% |
* Healthcare Sector Average
JP:6034
MRT Inc.
631.00
11.00
1.77%
JP:3628
Data Horizon Co., Ltd.
508.00
167.00
48.97%
JP:3902
Medical Data Vision Co.Ltd.
1,683.00
1,348.00
402.39%
JP:4438
Welby Inc.
341.00
63.00
22.66%
JP:9218
Mental Health Technologies Co. Ltd.
754.00
93.64
14.18%
JP:366A
Wellness Communications Corporation
1,021.00
-742.59
-42.11%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.